Merck (MRK) Non-cash Items (2012)

Merck (MRK) reported Non-cash Items of $149.4 million for Q4 2012.

Merck (MRK) Non-cash Items (2012) Analysis & Trends

Merck (MRK) has 1 years of Non-cash Items data on file, last reported at $149.4 million in Q4 2012.

Non-cash Items for Q4 2012 came in at $149.4 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2012 was $149.4 million (changed N/A YoY), and the FY2012 annual result was $149.4 million, changed N/A from the prior year.
Non-cash Items steadied at $149.4 million in Q4 2012 per MRK's latest filing.
Over five years, Non-cash Items peaked at $149.4 million in Q4 2012 and troughed at $149.4 million in Q4 2012.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Gsk	92,316,836.42 Bn	92,316,831.46 Bn	7.76 Bn
2	Eli Lilly	983.57 Bn	978.29 Bn	16.22 Bn
3	Johnson & Johnson	553.56 Bn	531.50 Bn	15.96 Bn
4	AbbVie	383.35 Bn	374.00 Bn	10.78 Bn
5	Merck	281.71 Bn	276.06 Bn	12.09 Bn
6	Amgen	182.20 Bn	170.16 Bn	5.87 Bn
7	Gilead Sciences	153.71 Bn	145.98 Bn	5.52 Bn
8	Pfizer	143.75 Bn	130.98 Bn	-1.21 Bn
9	Bristol Myers Squibb	109.71 Bn	99.25 Bn	8.07 Bn
10	Novartis Ag	108.28 Bn	107.60 Bn	-

Historic Data

Download Data

Date	Value
Dec 31, 2012	149.41 Mn
Dec 31, 2012	149.41 Mn